Does RELATLIMAB Cause Pericardial effusion? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Pericardial effusion have been filed in association with RELATLIMAB. This represents 3.4% of all adverse event reports for RELATLIMAB.
6
Reports of Pericardial effusion with RELATLIMAB
3.4%
of all RELATLIMAB reports
0
Deaths
6
Hospitalizations
How Dangerous Is Pericardial effusion From RELATLIMAB?
Of the 6 reports, 6 (100.0%) required hospitalization, and 3 (50.0%) were considered life-threatening.
Is Pericardial effusion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RELATLIMAB. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does RELATLIMAB Cause?
Pneumonia (13)
Malignant neoplasm progression (9)
Myocarditis (8)
Hypotension (7)
Meningitis aseptic (7)
Pyrexia (7)
Sepsis (7)
Adrenal insufficiency (6)
Drug ineffective (6)
Hepatitis (6)
What Other Drugs Cause Pericardial effusion?
TREPROSTINIL (584)
IBRUTINIB (467)
CYCLOPHOSPHAMIDE (458)
NIVOLUMAB (454)
METHOTREXATE (412)
MACITENTAN (407)
DASATINIB (388)
ADALIMUMAB (374)
AMBRISENTAN (371)
PEMBROLIZUMAB (362)
Which RELATLIMAB Alternatives Have Lower Pericardial effusion Risk?
RELATLIMAB vs RELPAX
RELATLIMAB vs RELUGOLIX
RELATLIMAB vs REMDESIVIR
RELATLIMAB vs REMERON
RELATLIMAB vs REMICADE